MAPK1 and hepatocellular carcinoma: In addition, downregulation of the ERK/MAPK signaling pathway activity was not found to be involved in the CsA reversal function, which indicates that inhibiting ERK/MAPK signaling pathway activity is not a unique method to reverse MDR in HCC cells.